×
About 2,163 results

ALLMedicine™ Melasma Center

Research & Reviews  607 results

Intradermal injection of tranexamic acid versus platelet-rich plasma in the treatment o...
https://doi.org/10.1007/s00403-023-02580-y
Archives of Dermatological Research; Abd Elraouf IG, Obaid ZM et. al.

Mar 2nd, 2023 - Millions of people throughout the world suffer from the acquired condition of hyperpigmentation known as melasma. Melasma is characterized by symmetrically oriented hyperpigmented macules and patches. Many treatment options are available with vari...

The dermoscopic characteristics of melasma in relation to different skin phototypes, di...
https://doi.org/10.1007/s00403-023-02584-8
Archives of Dermatological Research; Bostan E, Cakir A

Mar 1st, 2023 - Melasma is an acquired, pigmentary disorder characterized by the appearance of brown to bluish-gray patches with well-demarcated or ill-defined borders, most commonly on the face. This challenging hyperpigmentation disorder is generally observed i...

The mechanism of Croci stigma in the treatment of melasma based on network pharmacology...
https://doi.org/10.1111/jocd.15682
Journal of Cosmetic Dermatology; Yin W, Zhao F et. al.

Mar 1st, 2023 - To investigate the molecular mechanism of Croci stigma (CS) in the treatment of melasma by network pharmacology and molecular docking. TCMSP, CTD, STITCH, SymMap, GeneCard, GenBank, OMIM and DrugBank databases were used to obtain the components an...

Comparative effectiveness and safety of topical methimazole 5% monotherapy versus combi...
https://doi.org/10.1111/jocd.15641
Journal of Cosmetic Dermatology; Beyzaee AM, Goldust M et. al.

Feb 28th, 2023 - Melasma is an acquired pigmentary disorder which currently has no definitive treatment. Although topical drugs containing hydroquinone are the basis of treatments, they are usually associated with recurrence. We aimed to evaluate the effectiveness...

A Pilot Study Testing Salicylic Acid Peels Versus Glycolic Acid Peels for the Treatment of Melasma
https://clinicaltrials.gov/ct2/show/NCT01976286

Feb 21st, 2023 - Participants in this study will be patients who are clinically diagnosed with at least a 2 x 2 cm patch of melasma on each side of their face (forehead or cheek). One half of the subject's face will be randomly selected to receive 4 treatments of ...

see more →

Drugs  45 results see all →

Clinicaltrials.gov  104 results

A Pilot Study Testing Salicylic Acid Peels Versus Glycolic Acid Peels for the Treatment of Melasma
https://clinicaltrials.gov/ct2/show/NCT01976286

Feb 21st, 2023 - Participants in this study will be patients who are clinically diagnosed with at least a 2 x 2 cm patch of melasma on each side of their face (forehead or cheek). One half of the subject's face will be randomly selected to receive 4 treatments of ...

Tolerance of Cyto-selective Difluoroethane-based Cryotherapy in the Treatment of Post-inflamamatory Hyperpigmentation (PIH).
https://clinicaltrials.gov/ct2/show/NCT05495503

Feb 8th, 2023 - Background: Hyperpigmentation is a problem in all skin types. Safe depigmentation is a challenge. Cryotherapy with liquid nitrogen at -70 °C has been used in the treatment of solar skin lesions for many years but causes considerable damage. Difluo...

Effects of RF Microneedle on Photoaging Skin
https://clinicaltrials.gov/ct2/show/NCT05710068

Feb 2nd, 2023 - Melasma relapse is almost common after discontinuation of conventional treatment. Recent studies have suggested that photoaging dermis is main pathomechanism of melasma emphasizing stromal targeting therapy. Therefore, we investigated maintenance ...

Comparison of a New Masterful Preparation to Kligman's Trio in the Treatment of Melasma
https://clinicaltrials.gov/ct2/show/NCT05119413

Jan 27th, 2023 - Kligman's trio remains the gold standard treatment for melasma. It contain hydroquinone which is an effective anti-melanogenic compound but that has poor tolerance and numerous side-effects. Thiamidol has been proven to be at least as effective as...

Tissue-resident Memory T Cells Expression in Melasma
https://clinicaltrials.gov/ct2/show/NCT05698342

Jan 26th, 2023 - Melasma is a common, acquired pigmentary disorder characterized by chronic and relapsing hypermelanosis on sun-exposed areas that causes significant emotional and psychosocial impact in patients mainly in women with Fitzpatrick III-V phototypes. T...

see more →

News  106 results

Long-term maintenance required in melasma patients
https://www.mdedge.com/dermatology/article/260463/pigmentation-disorders/long-term-maintenance-required-melasma-patients
Doug Brunk

Jan 4th, 2023 - SAN DIEGO – When Arisa E. Ortiz, MD, meets with patients who seek treatment for melasma, she tells them that while she can make their hyperpigmentation better, no cure-all exists for the condition.

Why it’s important to offer cosmeceuticals in a cosmetic practice
https://www.mdedge.com/dermatology/article/260462/aesthetic-dermatology/why-its-important-offer-cosmeceuticals-cosmetic
Doug Brunk

Jan 4th, 2023 - SAN DIEGO – While laser procedures, injectables, and chemical peels may be considered the bread and butter of a cosmetic dermatology practice, don’t forget about cosmeceuticals, advised Ava Shamban, MD. Dr.

Applications for laser-assisted drug delivery on the horizon, expert says
https://www.mdedge.com/dermatology/article/259988/medical-dermatology/applications-laser-assisted-drug-delivery-horizon
Doug Brunk

Dec 8th, 2022 - For those who view fractional ablative laser–assisted drug delivery as a pie-in-the-sky procedure that will take years to work its way into routine clinical practice, think again. Dr.

ICD-10 code can identify patients with melasma for future study
https://www.mdedge.com/dermatology/article/259381/pigmentation-disorders/icd-10-code-can-identify-patients-melasma-future
Jeff Craven

Nov 10th, 2022 - To better understand melasma, it is important for researchers to find groups of patients with confirmed disease for future clinical study. A recent research letter published in JAMA Dermatology suggests the ICD-10 code for melasma is a good identi.

Artemisia capillaris extract
https://www.mdedge.com/dermatology/article/257902/aesthetic-dermatology/artemisia-capillaris-extract
Leslie S. Baumann, MD

Sep 16th, 2022 - Melasma is a difficult disorder to treat. With the removal of hydroquinone from the cosmetic market and the prevalence of dyschromia, new skin lightening ingredients are being sought and many new discoveries are coming from Asia.

see more →

Patient Education  3 results see all →